Intervention (App Arm) for Human Immunodeficiency Virus (HIV) Infection
Study Summary
This trial tests if a mobile app helps people living with HIV quit smoking.
- Smoking Cessation
- Human Immunodeficiency Virus (HIV) Infection
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 12 weeks after baseline (or quit date if later than baseline visit)
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control
1 of 2
Intervention (App Arm)
1 of 2
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention (App Arm) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this research project currently facilitating enrolment of participants?
"Affirmative. Clinicaltrials.gov's information demonstrates that, as of 1/1/2023 this medical trial is actively seeking participants to enrol in its program. The study was last updated on 11/4/2022 and requires 60 volunteers from a single site." - Anonymous Online Contributor
What is the volume of participants currently enrolled in this clinical experiment?
"Correct. Details on clinicaltrials.gov verify that this research trial is still actively looking for participants; it was first published on the 1st of January 2023 and most recently updated on November 4th 2022. The medical centre needs to enlist 60 individuals in total from a single location." - Anonymous Online Contributor